BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 38486152)

  • 1. Isolation and characterization of lytic bacteriophages from various sources in Addis Ababa against antimicrobial-resistant diarrheagenic Escherichia coli strains and evaluation of their therapeutic potential.
    Sada TS; Tessema TS
    BMC Infect Dis; 2024 Mar; 24(1):310. PubMed ID: 38486152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and Characterization of Novel Lytic Phages Infecting Multidrug-Resistant Escherichia coli.
    Vera-Mansilla J; Sánchez P; Silva-Valenzuela CA; Molina-Quiroz RC
    Microbiol Spectr; 2022 Feb; 10(1):e0167821. PubMed ID: 35171030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation, characterization, therapeutic potency, and genomic analysis of a novel bacteriophage vB_KshKPC-M against carbapenemase-producing Klebsiella pneumoniae strains (CRKP) isolated from Ventilator-associated pneumoniae (VAP) infection of COVID-19 patients.
    Mohammadi M; Saffari M; Siadat SD; Hejazi SH; Shayestehpour M; Motallebi M; Eidi M
    Ann Clin Microbiol Antimicrob; 2023 Feb; 22(1):18. PubMed ID: 36829156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Lytic Bacteriophages Infecting Multidrug-Resistant Shiga Toxigenic Atypical
    Montso PK; Mlambo V; Ateba CN
    Front Public Health; 2019; 7():355. PubMed ID: 32039126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and Characterization of Lytic Bacteriophages Active against Clinical Strains of
    Alexyuk P; Bogoyavlenskiy A; Alexyuk M; Akanova K; Moldakhanov Y; Berezin V
    Viruses; 2022 Oct; 14(11):. PubMed ID: 36366479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacteriophage cocktail and phage antibiotic synergism as promising alternatives to conventional antibiotics for the control of multi-drug-resistant uropathogenic Escherichia coli.
    Malik S; Nehra K; Rana JS
    Virus Res; 2021 Sep; 302():198496. PubMed ID: 34182014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of two bacteriophages with lytic activity against multidrug-resistant Escherichia coli.
    Fu P; Zhao Q; Shi L; Xiong Q; Ren Z; Xu H; Chai S; Xu Q; Sun X; Sang M
    Virus Res; 2021 Jan; 291():198196. PubMed ID: 33098914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A lytic phage to control multidrug-resistant avian pathogenic
    Yao L; Bao Y; Hu J; Zhang B; Wang Z; Wang X; Guo W; Wang D; Qi J; Tian M; Bao Y; Li H; Wang S
    Front Cell Infect Microbiol; 2023; 13():1253815. PubMed ID: 37743864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. |Isolation and characterization of novel bacteriophages as a potential therapeutic option for Escherichia coli urinary tract infections.
    González-Villalobos E; Ribas-Aparicio RM; Montealegre GER; Belmont-Monroy L; Ortega-García Y; Aparicio-Ozores G; Balcázar JL; Eslava-Campos CA; Hernández-Chiñas U; Molina-López J
    Appl Microbiol Biotechnol; 2021 Jul; 105(13):5617-5629. PubMed ID: 34254156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and Identification of
    Sjahriani T; Wasito EB; Tyasningsih W
    Int J Food Sci; 2021; 2021():7383121. PubMed ID: 34423027
    [No Abstract]   [Full Text] [Related]  

  • 11. Characterising the biology of novel lytic bacteriophages infecting multidrug resistant Klebsiella pneumoniae.
    Kęsik-Szeloch A; Drulis-Kawa Z; Weber-Dąbrowska B; Kassner J; Majkowska-Skrobek G; Augustyniak D; Lusiak-Szelachowska M; Zaczek M; Górski A; Kropinski AM
    Virol J; 2013 Mar; 10():100. PubMed ID: 23537199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacteriophage activity against and characterisation of avian pathogenic Escherichia coli isolated from colibacillosis cases in Uganda.
    Kazibwe G; Katami P; Alinaitwe R; Alafi S; Nanteza A; Nakavuma JL
    PLoS One; 2020; 15(12):e0239107. PubMed ID: 33320859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and evaluation of cocktail phages for the control of multidrug-resistant Escherichia coli serotype O104: H4 and E. coli O157: H7 isolates causing diarrhea.
    Safwat Mohamed D; Farouk Ahmed E; Mohamed Mahmoud A; Abd El-Baky RM; John J
    FEMS Microbiol Lett; 2018 Feb; 365(2):. PubMed ID: 29253127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Antibacterial Effects of Cocktail and Single Forms of Lytic Phages Belonging to
    Jokar J; Rahimian N; Ghasemian A; Najafipour S
    Biomed Res Int; 2022; 2022():7833565. PubMed ID: 36467878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The comparison of lytic activity of isolated phage and commercial Intesti bacteriophage on ESBL producer E. coli and determination of Ec_P6 phage efficacy with in vivo Galleria mellonella larvae model.
    Erol HB; Kaskatepe B; Ozturk S; Safi Oz Z
    Microb Pathog; 2022 Jun; 167():105563. PubMed ID: 35513294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and Phenotypic Characterization of Virulent Bacteriophages Against Multidrug-Resistant
    Fikadu A; Amankwah S; Alemu B; Alemu Y; Naga A; Tekle E; Kassa T
    Infect Drug Resist; 2024; 17():293-303. PubMed ID: 38293311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and Physiomorphological Characterization of
    Litt PK; Jaroni D
    Int J Microbiol; 2017; 2017():7013236. PubMed ID: 29123549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lytic bacteriophages against multidrug-resistant Staphylococcus aureus, Enterococcus faecalis and Escherichia coli isolates from orthopaedic implant-associated infections.
    Barros J; Melo LDR; Poeta P; Igrejas G; Ferraz MP; Azeredo J; Monteiro FJ
    Int J Antimicrob Agents; 2019 Sep; 54(3):329-337. PubMed ID: 31229670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and Lytic Activity of Isolated
    Rahimzadeh G; Resch G; Rezai MS; Nemati Hevelaee E
    Iran J Med Sci; 2020 Jul; 45(4):298-303. PubMed ID: 32801419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and characterization of a potentially novel Siphoviridae phage (vB_SsapS-104) with lytic activity against Staphylococcus saprophyticus isolated from urinary tract infection.
    Yazdi M; Bouzari M; Ghaemi EA
    Folia Microbiol (Praha); 2019 May; 64(3):283-294. PubMed ID: 30284669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.